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Abbreviations 
aBMD  areal bone mineral density 
AN  anorexia nervosa 
BA  bone area 
BMAD  bone mineral apparent density 
BMC  bone mineral content 
BMD  bone mineral density 
DXA  dual energy x-ray absorptiometry 
ED  eating disorder 
FM  fat mass 
ISCD  International Society of Clinical Densitometry 
LM  lean mass 
LS  lumbar spine 
ppBA   percent predicted bone area 
ppBMC percent predicted bone mineral content 
SDS  standard deviation score 
TB  total body 
TBLH  total body less head 
VFA  vertebral fracture assessment  
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Abstract 
Background: Anorexia nervosa (AN) during childhood and adolescence has been reported to 
adversely affect bone health, but few studies have investigated longitudinal changes. 
Method: DXA-derived bone parameters and body composition were retrospectively assessed 
in 111 young girls with AN with a median age of 15.4 years (10.9, 19.8).  In 68 (61%) vertebral 
fracture assessment (VFA) was performed and in 31 (28%), a follow-up DXA was performed. 
Correlations with growth, changes in body composition and effects of illness duration and 
menstruation were examined.  Size adjusted DXA standard deviation scores were calculated 
for total body (TB) less head bone mineral content (TBLH-BMC) and lumbar spine bone 
mineral apparent density (LS-BMAD) 
Results: Mean (range) bone area (BA) for height centile was 27.1 (0-97), and mean lean mass 
for height centile was 28.8 (0-95) at baseline.  Mean (range) LS BMAD was -1.0 (-2.6, 0.8) SDS 
at first and -1.2 (-3.0, -0.2) at second DXA (p=0.023).   On follow up, lean mass for height 
increased from 27th centile (0, 75) to 40th centile (0, 70) (p=0.006), and fat mass for height 
increased from 55g/cm to 67g/cm (11.3, 124.2) (p<0.001).  Duration of illness was the only 
negative predictor of LS BMAD (p<0.0001).  Change in height SDS was the only positive 
predictor of change in TBLH-BMC (r=0.384, p=0.037), and change in LS BMAD (r-0.934, 
p<0.0001).  Of 68 patients who had VFA, 4 (5.9%) had a mild vertebral fracture. 
Conclusion: Bones are smaller and less dense in childhood/adolescent AN compared to 
healthy adolescents.  Although there are significant gains in lean mass and fat mass, over 
time, BMAD SDS decreases slightly.  Improvement in BMAD SDS is related to improvement in 
height SDS.    
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Introduction 
Anorexia nervosa (AN) is an eating disorder characterised by low body weight/body mass 
index (BMI) secondary to a fear of weight gain and distorted body image [1].  Abnormal bone 
density and increased fracture risk has been reported in 85% of adult women with AN. The 
average annual loss of bone density in AN is approximately 2.5% [2-4].   
The majority of adult bone mass is accrued during the transition from childhood to 
adolescence, corresponding to the period of peak incidence of AN.   Optimal nutrition is an 
important factor in the development of a healthy skeleton, and interruptions in nutritional 
balance during this critical time, through development of AN, can adversely affect the 
attainment of peak bone mass [5-8].   
AN may be further complicated by dysregulation of the growth hormone, gonadal and adrenal 
axes, which together may further compromise bone mass accrual through decreased bone 
formation[9].   
Bone strength is the result of not only bone density, but also bone mass and geometry [10].  
Dual energy x-ray absorptiometry (DXA) is the preferred clinical method of bone health 
assessment, mainly due to the low radiation dose, relatively low cost, and its ease of use.  
Interpretation of the two dimensional measure areal bone mineral density (aBMD) in g/cm2 
in childhood requires special consideration with results adjusted in reference to bone or body 
size [11-13]. The impact of chronic disease in children and adolescents, may be seen as 
inappropriate bone gain rather than bone loss witnessed in adulthood. A few studies have 
produced good quality size adjusted data in childhood/adolescent eating disorder over one 
year [14-15], but, to our knowledge, no studies have looked at changes in bone health over 
more than one year in AN, in children/adolescents relative to growth and body composition.   
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The aims of this study were : (1) to investigate factors such as body composition, duration of 
illness and frequency of periods and their effects on bone health;  (2) to assess longitudinal 
changes in bone area (BA),size adjusted bone mineral content (BMC) and lumbar spine bone 
mineral apparent density (BMAD) in a group of young patients with AN, using the recently 
published UK reference data [13]; (3) to investigate changes in bone parameters in relation 
to changes in anthropometry such as fat mass (FM), lean mass (LM), body mass index (BMI) 
and height SDS, and; (4) to quantify vertebral fracture (VF) in young girls with AN. 
 
Methods 
Subjects 
All females under the age of 20 years who were categorised by the referring physicians as 
having AN and referred for bone densitometry between January 2009 and February 2016 
were included in this retrospective review.  Referral for DXA was clinical, and in line with the 
Ionising Radiation Board recommendations.  No patients were reported to be on any bone 
active agents, or had any concomitant condition that could affect bone health.  Data were 
collected on duration of illness (time from diagnosis to first DXA scan), frequency of 
menstruation and family history of osteoporosis. This retrospective review did not require 
ethics approval or informed consent as it was conducted as part of healthcare evaluation of 
routine clinical practice and according to national guidance.   
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Growth and weight  
Height (cm) to the nearest 0.1cm was measured on a wall-mounted stadiometer (SECA, 
Germany).  Weight (kg) to the nearest 0.1kg was measured in light clothing on a SECA balance.  
Age and sex-adjusted standard deviation scores (SDS) for height, weight and BMI (kg/m2) 
were calculated using the LMS method based on UK population reference data [16]. 
 
Menstruation 
Frequency of periods was assessed in each female patient by the referring consultant.   This 
was categorised as normal (if they had monthly periods), as oligomennorhoea (if the period 
frequency was between two and six months), or as amenorrhoea (if they had no periods for 
greater than 6 months).  Girls who had not yet started their periods by the age of 15.9 years 
were categorised as normal, whereas, girls who had not started their periods aged 16.0 years 
and older were categorised as having amenorrhoea.  The normal category was also sub-
divided into premenarchal and postmenarchal. 
 
Dual Energy X-ray absorptiometry (DXA) 
 Total body (TB) and lumbar spine (LS) DXA scans were obtained on 111 (girls) subjects using 
narrow fan beam technology on a Lunar Prodigy scanner (2009- June 2015) driven by Encore 
Software Version 13.0 (GE, Wisconsin, USA), or iDXA (July 2015-February 2016) driven by 
Encore Software Version 15.0 (GE, Wisconsin, USA). Additionally, 31 girls had a follow up DXA.  
We considered it justifiable to use the two different machines with two versions of software 
for longitudinal measures, as there are strong linear relationships between GE scanners and 
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software when applying the basic analysis, [13].  Furthermore, the individual equations were 
applied when using the UK dataset for calculating TBLH-BMC SDS and BMAD SDS for data 
obtained on Prodigy and iDXA models. 
 As outlined in previous studies, reference data were used to calculate the bone area (BA) in 
cm2 and bone mineral content (BMC) in grams for age and sex [17-18].  This approach provides 
a percentage predicted bone area for age and a percentage predicted BMC for bone area.  
Moreover, by using linear interpolation, these data give predicted and percentage predicted 
bone area for age and sex.  
 
 Additionally, the newly published scanner-specific UK bone density dataset [13] was applied 
to calculate total body less head (TBLH) BMC (g) and LS bone mineral apparent density 
(BMAD) (gcm3) values.  Lean mass (LM) and fat mass (FM) values were derived from the TB 
DXA scan and expressed in g/cm height for the multiple regression analysis.  The 
manufacturer’s software also afforded centiles for BA for height, LM for height, and BMC for 
LM for direct comparison with a healthy Caucasian population.  A bone parameter value was 
considered low if it was greater than 10% below the predicted mean values for the individual.  
The coefficient of variation (%CV) was < 1% calculated on the manufacturer’s phantom, and 
2.1 % and 2.5% respectively for BMC and BA calculated on 30 repeat paediatric LS scans.   
 
Vertebral Fracture Assessment 
Of the 111 cases, 68 (61%) had a lateral spine DXA for VFA as part of their bone assessment.  
All patients had T6- L5 acquired with standard machine protocol [19].  Lateral spine images 
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were analysed as previously described [20].   Lateral spine images were analysed 
independently by two non radiologist observers, who performed VFA in all 68 cases.  Before 
commencing the VFA analysis, the observers defined a common protocol for point placement 
on each vertebral body.  Each observer manually identified six landmarks corresponding to 
the four corners and the midpoints of the endplates, retrospectively, of each adequately 
visualised vertebral body starting at L4 and continuing through the thoracic spine up to T6.  
From these points, the software measured the anterior, middle and posterior heights, and 
calculated the anterior:posterior height ratio and the middle:posterior height ratio within a 
vertebral body.  The observers also calculated the posterior:posterior height ratio when 
comparing the vertebrae above and below the one under examination [20].  The vertebral 
bodies were classified according to the extent of any height reduction as expressed by the 
reduction in height ratios using the scoring system developed by Genant:  grade 0 (no 
fracture) if the reduction of any height ration was <20%, grade 1 (mild VF) if a height ratio 
reduction was from 20% to 25%, grade 2 (moderate VF) if the decrement was 25 to 40%, and 
grade 3 (severe VF) if a height ratio reduction exceeded 40% [21]. 
 
Statistics 
All statistical analysis was undertaken using IBM SPSS (Version 22).  All data were reported as 
mean with range.  As data were normally distributed, one sample T Tests were used to 
investigate significant difference between groups.  Significant difference was deemed where 
the value was below p=0.05.  Pearson’s test statistic was used to derive simple linear 
correlations, and multiple regression analysis was used to predict the value of variables based 
on the value of two or more other variables. 
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Results 
In the cross sectional analysis, there were 111 Caucasian girls who attended for at least one 
DXA scan.  The mean (range) age of the girls was 15.4 (10.9, 19.8), and there were 42 (37.8%) 
who were described as having normal gonadal function, 18 (42.8%) of whom were 
appropriately pre-menarchal, and 24 (57.1%) were menarchal.  The remaining 69 girls had 
abnormal gonadal function: 11 girls (15.9%) with oligomenorrhoea, and 58 girls (84.1%) with 
amenorrhoea.  On questionnaire survey, none of the patients reported a history of 
osteoporosis or non-vertebral fracture.  On  semiquantitative assessment [20-21], of the 68 
patients, two showed a mild wedge fracture at T11, one a mild wedge fracture at T4 and one 
a mild biconcave fracture at T11. 
 
3.1.1 Anthropometry/body composition 
The AN group had mean height SDS -0.3 (range -3.8, 1.8) and had low weight SDS (mean -1.4, 
range -3.9, 1.1) and BMI SDS (mean -1.5, range -5.2, 1.6).  BMI SDS was below -2.0 in 29% of 
the study group.  The lean mass for height centile mean was 28.1 (range 0, 95), which was 
also skewed lower than that of the healthy population (Table 1). 
 
3.1.2 Bone parameters 
Mean (range) bone area (BA) was 1835cm2 (1265, 2428) and 36.4cm2 (24.4, 50.4) at the TB 
and LS sites in AN patients.  Mean BA for height centile, as derived from the encore DXA 
software, was 27.1% (range 1, 97) compared to mean for healthy controls.  Likewise, TB ppBA 
for age was low in AN patients (90%, 66, 113) as compared to healthy control data.  However, 
at the LS site, ppBA for age (mean 96.4, range 65.1, 135.0) was normal. 
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The mean (range) TBLH-BMC SDS was 0.7 (-1.8, 4.8) for AN patients which did not differ 
significantly from the healthy population.  However, at the LS site, mean BMAD SDS was -1.0 
(-3.2, 2.0) SDS, which was below 90% of the predicted value.   
 
3.1.3 Correlations between bone and anthropometrics/body composition 
In the univariate analysis of 111 young girls with AN, there was a significant correlation 
between BMI SDS and bone size at TB site and LS sites as shown in Supplementary Table 1.   
The correlation between TB ppBA for age and BMI was r=0.44 (p<0.0001), and between LS 
ppBA for age and BMI was r=0.33 (p<0.001).   Bone mineralisation parameters (ppBMC for 
BA) did not correlate with BMI SDS at TB, nor with LS BMAD, nor were there any correlations 
between height SDS, weight SDS, LM/height or FM/height and bone mineralisation 
parameters (Supplementary Table 1).   
TB ppBMC for BA correlated negatively with duration of illness (r=-0.28, p=0.002), as did TBLH-
BMC SDS (r=-0.24, p=0.009), and LS BMAD (r=-0.61, p<0.0001).  Frequency of periods was an 
independent predictor of LS BMAD (r= -0.31, p=0.001).  Multivariate analysis was applied, that 
included frequency of periods, LM, FM, duration of illness, height and BMI as predictors of 
TBLH-BMC, TB ppBMC for BA, and LS BMAD, (Table 3).  For TBLH-BMC SDS, FM (p<0.0001), 
LM (p=0.001) and duration of illness (p=0.003) were negative predictors and height 
(p<0.0001) and BMI (p<0.0001) were positive predictors.  For TB ppBMC for BA, duration of 
illness (p=0.005) was a negative predictors, and there were no positive predictors.  Duration 
of illness (p<0.0001) was a negative predictor of LS BMAD.  Frequency of periods was no 
longer a predictor of bone mineralisation in the multivariate model. 
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3.1.4 Follow up DXA group 
Of the 111 female children/adolescents, 31 (28%) had a follow up scan.  Mean time to follow 
up was 1.8 years (0.9 -5.7 years).   
 
3.1.5 Anthropometrics and bone parameters at follow-up 
The anthropometric characteristics and bone parameters for all patients at first and second 
DXA, and annual change in these parameters are reported in Table 2.  Mean (range) height 
increased from 158.7cm (147.0, 170.7) to 161.1cm (149.2, 171.0) at first and second DXA scan 
respectively (p<0.001), however, mean height SDS was unchanged.  There was a significant 
change in mean weight from 41.6kg (31.2, 53.6) at first DXA to 45.1 (33.8, 69.7) at second DXA 
(p=0.002), however, weight SDS remained the same (Table 2).  Likewise, mean BMI changed 
from 16.5 (13.1, 19.6) at first DXA to 17.6 (13.6, 24.9) at second DXA (p=0.014), but mean BMI 
SDS was unchanged.  There was also a significant increase in mean FM/height from 54.5g/cm 
(21.7, 90.7) to 66.5g/cm (11.3, 124.2) at first and second DXA respectively (p=0.006), but LM 
for height centile did not change (Table 2).  Mean bone size (BA cm2) increased at the TB site 
from 1799.8 cm2 (1288, 2285) at first DXA to 1914.5 cm2 (1510, 2320) at second DXA scan 
(p<0.001).  Likewise, at the LS site, mean BA increased from 36.4cm2 (28.1, 44.2) at first DXA 
to 37.9cm2 (31.8, 47.2) at second scan (p=0.001).  Mean bone mineral content at TB, did not 
change significantly over the course of the study, nor did mean TB ppBMC for BA (Table 2).  
However, mean BMAD reduced from -1.0 SDS at first DXA to -1.2 at second scan (p=0.023). 
 
3.1.6 Correlations between bone and body composition in the follow-up group 
In univariate analysis, and in terms of bone size, annual change in ppBA for age did not 
correlate with annual change in BMI SDS at TB (p=0.276), or LS sites (p=0.443). Likewise, 
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annual change in ppBA for age did not correlate with annual change in height SDS at TB 
(p=0.913), or LS (p=0.385), or with annual change in weight SDS at TB (p=0.190) or LS 
(p=0.512).  Annual change in bone size (ppBA for age) did not correlate with annual change in 
FM/height at either TB (p=0.979) or LS (p=0.900). 
 
In univariate analysis, and in terms of bone mineralisation, annual change in ppBMC for BA at 
TB did not correlate with annual change in BMI SDS (p=0.925).  There was no relationship 
between annual change in BMI SDS and annual change in LS BMAD (p=0.166), nor between 
annual change in BMI SDS and annual change in LS ppBMC for BA (p=0.261).  There was a 
positive correlation between annual change in TBLH-BMC SDS and annual change in height 
SDS (r=0.384, p=0.037), but not between annual change in TB ppBMC for BA and annual 
change in height SDS (p=0.808).  There was a strong correlation between change in BMAD 
and change in height SDS (r=0.934, p<0.0001).  Annual change in weight SDS correlated 
negatively with annual change in TBLH-BMC SDS (r=-0.470, p=0.008), but did not correlate 
with annual change in TB ppBMC for BA (p=0.736), or with annual change in BMAD (p=0.416). 
 
There was no relationship between change in LM and change in TB ppBMC for BA (p=0.817), 
or change in LS BMAD (p=0.393.  Change in FM/height did not correlate with change in TB pp 
BMC for BA (p=0.458), or change in BMAD (p=0.197). 
 
On multivariate analysis that included change in LM/height, change in FM/height, change in 
weight SDS and change in height SDS, as predictors of change in TB ppBMC for BA and change 
in LS BMAD (Table 4), change in height SDS was the only predictor of change in LS BMAD 
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(r=0.926, p<0.0001).  The relationship between TBLH-BMC SDS and height SDS and between 
LS BMAD and height SDS is shown in Figure 1. 
 
Discussion 
Most studies in young AN patients report areal BMD (aBMD) rather than size adjusted bone 
parameters.  However, due to the size dependency of aBMD, failure to size correct data can 
potentially lead to an overestimation of the prevalence of osteoporosis in patients with 
smaller than normal bones.  Strengths of this study include the large sample size and the use 
of two different methods of size adjustment to calculate the DXA bone parameters.  By doing 
this, we are able to differentiate bone size from bone mineralisation.  This is the first study to 
our knowledge that looks at bone accrual in relation to linear growth in young people with 
AN. 
 
Low BMI was reported in the present study, with 29% of girls with AN having BMI SDS less 
than -2.0, suggesting that almost a third of our group exhibit nutritional deficits at time of first 
DXA scan.  A low percentage median BMI has been reported as a negative predictor of bone 
parameters at multiple sites [22].  We showed that the area of the skeleton was 10% smaller 
in AN compared to healthy children.  This result is in keeping with Stone et al [14], who 
reported narrower bones in AN using the Møldgaard approach of size adjustment [11].  
However, our height SDS was also slightly below average for AN (-0.3 SDS), which suggests 
bones are slightly shorter than normal.  The reduced height status reported in the present 
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study could be due to the longer study duration, which was mean 1.8 years follow-up 
compared to only 12 months in previous studies [14].   
 
Female children and adolescents with AN showed reduced LM compared to healthy controls, 
but appeared to have adequate TB BMC for the given LM.  This result is in agreement with 
others [14], who reported low lean mass in patients with AN.  In health, muscle and bone are 
very closely related, in that lean mass strongly predicts bone mineral content [23].  However, 
from the multiple regression analysis in the current study, there was a negative relationship 
between lean mass and bone, and between FM and bone, hence there appears to be a 
mismatch in the muscle-bone relationship in AN.  One could speculate that this is most likely 
due to sudden loss of lean mass and fat mass in patients who are restricting their nutritional 
intake.  Therefore, as soft tissue loss precedes bone loss, in the short term, the BMC could be 
high for the given lean mass (and FM).  Hence, TBLH-BMC SDS, which are predicted from LM, 
FM, height and age, appear normal in this patient group.  The current study showed in our 
follow up cohort, that LM/ht and FM/height increased in AN over time.  Others have reported 
increased percent FM coupled with decreased percent LM [24].   
 
In children and adolescents, bone is modelling rather than remodelling, hence, one would not 
expect to see bone loss in young patients, but rather inappropriate gain compared to size and 
gender matched controls.  This can be demonstrated by a reduction in the SDS rather than 
change in absolute values.  Such deficit in bone mineral accrual was significant at the LS, as 
could be seen from the reduced BMAD SDS in the follow up of AN girls.  The decline in BMAD 
SDS over time seen in the current study did not correlate with a change in BMI, LM or FM but 
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did correlate with change in height SDS.  Deficits in LS BMAD have been associated with 
reduced frequency of menstruation, which has been attributed to oestrogen deficiency [25].  
However, an association between frequency of menses and bone mineralisation was not 
observed in the current study.   Restoration of menses has been shown to significantly 
improve BMD [24], but full recovery may not be attained [26].  Weight gain has been shown 
to lead to recovery of bone mineral deficits in some [5, 7, 26-29], but not all adolescent studies 
[14, 30-33].  These studies are reviewed extensively elsewhere [34]. 
 
Due to size dependency limitation [35], areal BMD as measured by DXA incorporates both 
bone size and bone mineralisation.  It is a two dimensional scan of a three dimensional object, 
therefore underestimates BMD in smaller children with smaller bones (short and/or slender).  
In the multiple regression model, BMI predicted bone mineralisation at TB, but not the LS site.  
We also showed from the univariate analysis that BMI influences bone size to greater extent 
than bone mineralisation.   
We report a vertebral fracture rate of 5.9% in childhood/adolescent ED in a population of 
children adolescents referred for bone density assessment.  This is comparable with 3.8% 
vertebral fractures reported by others [36], in a cross sectional analysis of 13-26 year old girls 
and young adults with AN (n=80).  According to DiVasta et al [36], the incidence of vertebral 
fracture is not predicted by BMI or BMD Z scores.  Although the current study did not have a 
large enough fracture group for reliable statistical analysis, our results showed, with size 
adjusted BMAD, that all four patients did have bone density scores of <-1.0 SDS.   
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There are several limitations to this study.  The TBLH-BMC SDS in the present study is 
calculated from an algorithm that includes LM, FM, height and age.  Hence, for patients with 
abnormally low LM and FM, these data should be interpreted with caution.  The use of DXA 
has also been criticised for its sensitivity and inability to differentiate between trabecular and 
cortical bone.  Due to the retrospective nature of this study, we were unable to determine 
which patients had been continually affected by their eating disorder, or which patients had 
been in periods of remission.  However, we were able to assess nutritional status with BMI 
SDS and change in BMI SDS status over time.  Additionally, we did not have access to blood 
samples in the present to determine bone biomarkers, or growth factors.  Furthermore, 
children/adolescents who were identified as having vertebral fractures did not undergo 
conventional x-ray for confirmation.  We recently reported low incidence of VF in young 
people with AN in comparison to other disease groups [37].  When considering asymptomatic 
vertebral fracture assessment, there are limited data on fracture incidence in healthy 
children/adolescents.  Therefore, we were unable to compare our VF data to the norm.   
 
In conclusion, bones are smaller in size and less dense in childhood/adolescent AN compared 
to healthy adolescents.  Deficits in bone mineralisation are apparent at the LS in AN, but not 
obviously at the TB.  As expected, bone size for age is related to BMI SDS.  On follow up, 
although there are significant gains in lean mass and fat mass, BMAD SDS decreases slightly.  
Improvement in BMAD SDS is related to improvement in height SDS, which suggests that the 
drive is for linear growth and bone accrual rather than an increase in body composition where 
calorific intake is limited.    
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Table 1. Characteristics of patients with anorexia nervosa 
 
Anorexia Nervosa 
Girls n (%) 111 (100%) 
Duration of illness (years) 1.7 (0.4, 6.0) 
Age (years) 15.4 (10.9, 19.8) 
Height (cm) 159.7 (136.3, 174.0) 
Height SDS -0.3 (-3.8, 1.8) 
Weight (kg) 43.7 (29.4, 66.1) 
Weight SDS -1.5 (-3.9, 1.1)* 
BMI (wt/ht
2
) 17.1 (12.8, 24.9)* 
BMI SDS -1.5 (-5.2, 1.6)* 
FM/height (g/cm) 59.8 (9.7, 116.1) 
TB BA (cm) 1835 (1265, 2428) 
TB ppBA for Age (%) 90.0 (66, 113)* 
TB pp BMC for BA (%) 98.5 (88, 116) 
TB BA for Ht (centile) 27.1 (1, 97)* 
TB LM for Ht  (centile) 28.8 (0, 95)* 
TB BMC for LM (centile) 52.3 (1, 99) 
TBLH BMC SDS 0.7 (-1.8, 4.8) 
LS BA (cm) 36.4 (24.4, 50.4) 
LS ppBA for Age (%) 96.4 (65.1, 135.0) 
LS BMAD SDS -1.0 (-3.2, 2.0)* 
All values mean (range).  * > 10% lower than healthy  
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Table 2. Characteristics of patients with anorexia nervosa at first and second DXA scan 
 
Initial DXA 
n= 31 
Follow up DXA 
n= 31  
∆/year P 
Age (years) 14.4 (11.1, 17.1) 16.2 (12.1, 19.8) 
  
Height (cm) 158.7 (147.0, 
170.7)  
161.1 (149.2, 
171.0) 
1.65 (0.0, 9.29) <0.001 
Height SDS -0.1 (-2.2, 1.2)  -0.2 (-1.7, 1.3) -0.16 (-1.56, 0.91) 0.079 
Weight (kg) 41.6 (31.2, 53.6) 45.1 (33.8, 69.7) 2.18 (-4.55, 12.08 0.002 
Weight SDS -1.4 (-3.8, 0.2)* -1.5 (-3.7, 1.3)* 0.75 (-2.7, 5.7) 0.182 
BMI (wt/ht
2
) 16.5 (13.1, 19.6) 17.6 (13.6, 24.9) 0.05 (-1.8, 1.54) 0.014 
BMI SDS -1.6 (-4.2, -0.4)* -1.5 (-4.5, 1.6) * 0.1 (-1.7, 2.0) 0.360 
LM  for height 
centile 27.29 (0, 75)* 39.58 (0, 70)* 
4.3 (-23.6, 44.2) <0.001 
FM/height (g) 
54.5 (21.7,  90.7) 66.5 (11.3, 124.2) 7.16 (-22.73, 
35.24) 
0.006 
BA at TB (cm
2
) 1799.8 (1288, 
2285) 
1914.5 (1510, 
2321) 
61.2 (-112.5, 222) <0.001 
TB ppBA for Age 
(%) 
92.3 (72, 124) 91.7 (75, 106) -1.2 (-10.7, 8) 0.335 
TB pp BMC for BA 
(%) 
97.2 (88, 108) 95.2 (84.9, 111) -1.0 (-9, 8) 0.027 
TB BA for Ht 
(centile) 
27.3 (2, 78)* 39.6 (2 , 97)* 6.2 (-47.8, 58) 0.009 
TB BMC for LM 
(centile) 
53.0 (6, 96) 49.8 (9, 99) -2.1 (-34.6, 28.3) 0.242 
TBLH BMC SDS 0.7 (-2.0, 3.8) 0.6 ( -1.4, 3.0) -0.15 (-2, 1.43) 0.208 
BA  at LS (cm
2
) 36.4 (28.1, 44.2) 37.9 (31.8, 47.2) 0.95 (-1.3, 5.1) 0.001 
LS BMAD SDS -1.0 (-2.6, 0.8)* -1.2 (-3.0, -0.2)* -0.18 (-1.6, 0.5) 0.023 
All values mean (range).  P value ≤ 0.05 deemed significant, * > 10% lower than healthy  
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Table 3.  Association between bone parameters and anthropometrics in patients with anorexia 
nervosa  (n=111): results of multivariable linear regression analysis 
 
Regression  standardised  β coefficient (95% confidence interval) and p 
value associated with each predictor 
 
TBLH-BMC SDS 
(R
2 
=0.311) 
TB pp BMC for BA 
(R
2 
=0.174) 
LS BMAD 
(R
2 
=0.389) 
Period 
frequency  
0.038 (-0.198,  
0.301) p=0.683 
0.040 (-0.967,  1.450) 
p=0.693 
-0.146 (-0.297,  0.025) 
p=0.096 
Fat mass -2.153 (0.001, 
0.000) p<0.0001 
-0.488 (-0.002,  0.001) 
p=0.339 
-0.220 (0.000 ,  0.000) 
p=0.615 
Lean mass -2.411 (0.001, 
0.000) p=0.001 
-0.140 (-0.002,  0.001) 
p=0.827 
-0.370 (0.000,  0.000) 
p=0.503 
Duration 
of illness 
-0.274 (-0.503 , -
0.105) p=0.003 
-0.255 (-2.217 , -0.289) 
p=0.011 
-0.581 (-0.571,  -
0.314) p<0.0001 
Height 2.386 (0.230 , 0.568) 
p<0.0001 
0.319 (-0.585,  1.057) 
p=0.569 
0.388 (-0.065,  0.154) 
p=0.422 
BMI 2.790 (0.983,  2.489) 
p<0.0001 
0.516 (-2.231,  5.075) 
p=0.442  
0.409 (-0.312,  0.661) 
p=0.478 
Correlations deemed significant where p<0.05 
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Table 4. Association between Δ bone parameters and  Δ anthropometrics in patients with 
anorexia nervosa (n=31): results of multivariable linear regression analysis 
 
Regression  standardised  β coefficient (95% confidence intervals) and p 
value associated with each predictor 
Annual 
change in 
parameter 
 
Δ TB pp BMC for BA 
(R
2 
=0.062) 
Δ LS BMAD 
(R
2 
=0.864) 
Δ  Fat 
mass/height 
 -0.245 (-0.211 ,  0.078) p=0.402 -0.148 (-0.011,  0.002) 
p=0.159 
Δ  Lean 
mass/height 
 0.449 (-1.733 ,  5.225) p=0.312 0.020 (-0.145,  
0.165)p=0.899 
Δ  Weight 
SDS 
 0-.269 (-6.276 ,  3.443) p=0.554 0.084 (-0.160 ,  0.271) 
p=0.600 
Δ  Height SDS  0.074 (-2.297,  3.316) p= 0.712 0.926 (0.669,  0.918) 
p<0.0001 
 
 
Correlations deemed significant where p<0.05 
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Highlights: 
 
 
1. Lumbar spine bone mineral apparent density reduces in girls with anorexia nervosa girls with 
illness greater than one year 
2. Changes in lumbar spine bone mineral apparent density are dependent on linear growth 
3. Vertebral fractures can occur in anorexic girls/adolescents referred for bone density scans 
4. It is important to take bone size into account in analysis of paediatric bone mineral density 
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